Updated on February 28th, 2020 by Josh Arnold
Real Estate Investment Trusts are popular investments among income investors, and for obvious reasons. They are required to pass along the vast
News
Nanobiotix 2019 Q4 and Annual Revenues
Regulatory News:
NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN : FR0011341205 – the ‘‘Company’’), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of
Insight Honors Companies Successfully Transforming Through Tech at Evolve 2020 Event
Insight Enterprises (NASDAQ:NSIT), the global integrator of Insight Intelligent Technology Solutions™ for organizations of all sizes, honored companies that are achieving success through digital
Craft Brew Alliance to Report Fourth Quarter and Full-Year 2019 Financial Results on March 11, 2020
Craft Brew Alliance, Inc. (“CBA”) (Nasdaq: BREW), a leading craft brewing company, today announced it will report fourth quarter and full-year 2019 financial results on Wednesday, March 11, 2020
Michelle M. MacKay Will Join Cushman & Wakefield as Chief Operating Officer
Cushman & Wakefield (NYSE: CWK) announced today that Michelle M. MacKay will join the firm as Chief Operating Officer (COO), stepping down from her role on the firm’s Board of Directors, effective
AgeX Therapeutics Researchers Publish Paper on the Age Reprogramming of Super-Centenarian Cells
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced a new paper co-authored by two AgeX
Puma Biotechnology to Present at Cowen’s Annual Health Care Conference
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of
Agilent Technologies Announces Webcasts for Investment Community
Agilent Technologies Inc. (NYSE: A) today announced the following webcasts for the investment community.
40th Annual Cowen And Company Healthcare Conference
Tuesday, March 3, 2020 at 10:00 a.m
Antibe Therapeutics Announces Enrollment of Last Patient in Phase 2B Dose-ranging, Efficacy Study of Lead Drug, ATB-346
Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer, non-addictive therapeutics for pain and inflammation, is pleased to announce that the
Sangamo Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today reported fourth quarter and full year 2019 financial results and recent business highlights.
“This quarter marked an
Marko Maras, CEO of Audiens accepted into Forbes Business Council
Marko Maras, CEO of Audiens, a global customer data platform that gives marketers an easy to use audience creation platform, has been accepted into the Forbes Business Council, the foremost growth
Fluidra Achieves Its Objectives in the First Full Year After the Merger With Zodiac
Fluidra closed 2019, the first full year after the merger, with growth across all main business indicators. The global leader in the pool and wellness equipment business closed 2019 with an
Notice of ABB’s Annual General Meeting on March 26, 2020
ABB today published the invitation to its Annual General Meeting (AGM), which will be held on Thursday, March 26, 2020. The invitation can be found on ABB’s investor relations website at www.abb.co
Helmerich & Payne, Inc. to Participate in the Credit Suisse 25th Annual Energy Summit In Vail, Colorado
Helmerich & Payne, Inc. (NYSE: HP) today announced that Mark Smith, Senior Vice President and CFO; John Bell, Vice President of International & Offshore Operations; and Dave Wilson, Director of
Biogen and Sangamo Announce Global Collaboration to Develop Gene Regulation Therapies for Alzheimer’s, Parkinson’s, Neuromuscular, and Other Neurological Diseases
Biogen Inc. (Nasdaq: BIIB) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that they have executed a global licensing collaboration agreement to develop
James Quincey Elected to Pfizer’s Board of Directors
Pfizer Inc. (NYSE: PFE) today announced the election of James Quincey to its Board of Directors, effective immediately. Mr. Quincey, age 55, was also appointed to the Compensation Committee and the
voxeljet AG Schedules Fourth Quarter 2019 Financial Results Release and Conference Call
voxeljet AG (NYSE:VJET) (the “Company” or “voxeljet”), a leading provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers, today
Cushman & Wakefield Reports Strong Revenue Growth for Fourth Quarter and Full Year 2019
Cushman & Wakefield (NYSE: CWK) today reported financial results for the full year and fourth quarter ended December 31, 2019 and provided 2020 guidance:
-
Revenue for the full year 2019 was $8.8
NCR Corporation Appoints Equifax CEO Mark W. Begor to its Board of Directors
NCR Corporation (NYSE: NCR) today announced that it has named Equifax Chief Executive Officer Mark W. Begor to its Board of Directors.
Mr. Begor has been CEO of Equifax, a leading global data
RealPage Reports Fourth Quarter and Full Year 2019 Financial Results
RealPage, Inc. (NASDAQ:RP), a leading global provider of software and data analytics to the real estate industry, today announced financial results for the fourth quarter and year ended December
Ladder Capital Corp Reports Results for the Quarter and Year Ended December 31, 2019 and Announces First Quarter 2020 Dividend to Holders of Class A Common Stock
Ladder Capital Corp (NYSE: LADR) (“we,” “Ladder,” or the “Company”) today announced operating results for the quarter ended December 31, 2019. GAAP income before taxes for the three months ended
Columbia Sportswear Company Provides Update on COVID-19 Impacts
Columbia Sportswear Company (Nasdaq: COLM), a global leader in designing, sourcing, marketing and distributing outdoor, active and everyday lifestyle apparel, footwear, accessories, and equipment
Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.
Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit relating to BGI’s “CoolMPS” sequencing products. The complaint was filed against BGI Genomics Co., Ltd
Polaris Inc. to Present at The Raymond James Institutional Investors Conference
Polaris Inc. (NYSE: PII) announced today that it will present at The Raymond James 41st Annual Institutional Investors Conference at the JW Marriott Grande Lakes in Orlando, Florida on Tuesday